Stroke:脑出血后神经功能障碍的时间进程和预测因素

2015-02-10 李志行 译 MedSci原创

神经功能障碍(ND)是脑出血后一种的非常严重的并发症,但是我们对其时间进程与预测因素知之甚少。研究方法:我们进行了一项回顾性队列研究,观察对象为脑出血试验中的安慰剂患者。我们分别在出现症状3小时内、24小时、72小时对患者行CT扫描,并对1小时、1至3天、15天的基线资料进行临床评价。我们对ND进行了如下定义:超急性(1小时内)、急性(1-24小时内)、亚急性(1-3天)、延迟性(3-15天)。研



神经功能障碍(ND)是脑出血后一种的非常严重的并发症,但是我们对其时间进程与预测因素知之甚少。

研究方法:

我们进行了一项回顾性队列研究,观察对象为脑出血试验中的安慰剂患者。我们分别在出现症状3小时内、24小时、72小时对患者行CT扫描,并对1小时、1至3天、15天的基线资料进行临床评价。我们对ND进行了如下定义:超急性(1小时内)、急性(1-24小时内)、亚急性(1-3天)、延迟性(3-15天)。

研究结果:

在我登记过的376名患者中有176名(47%)在15天内出现ND。通过分类对ND进行多因素分析,超急性ND与血肿扩张 ( OR, 3.6; 95% CI, 1.7–7.6)、出血量(OR, 1.02 per mL; 95% CI, 1.01–1.04)、格拉斯哥昏迷评分(OR, 0.77 per point; 95% CI, 0.65–0.91)以及心室出血(OR, 2.14; 95% CI, 1.05–4.35)有关;亚急性ND与72小时水肿 (OR, 1.03 per mL; 95% CI, 1.02–1.05)和发热(OR, 2.49; 95% CI, 1.01–6.14)有关。延迟性ND与年龄 (OR, 1.11 per year; 95% CI, 1.04–1.18)、肌钙蛋白 (OR, 4.30 per point; 95% CI, 1.71–10.77)以及感染(OR, 3.69; 95% CI, 1.11–12.23)有关。ND患者的90天改良Rankin评分相对较差。

研究结论:

ND在临床十分常见也提示较差的预后。我们的研究结果提示血肿扩张和心室出血常出现在ND早期,ND晚期常出现脑水肿、发热以及其他医疗并发症。

医学知识:格拉斯哥昏迷量表(GCS)


原始出处:

Aaron S. Lord, Emily Gilmore, H. Alex Choi, and Stephan A. Mayer , on behalf of VISTA-ICH Collaboration.Time Course and Predictors of Neurological Deterioration After Intracerebral Hemorrhage.Stroke 2015; first published on February 5 2015 as doi:10.1161/STROKEAHA.114.007704

本文是MedSci原创编译整理,转载需要事先获得授权!转载需要附来源及MedSci 原始链接。谢谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    以阅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1674666, encodeId=eaf416e466698, content=<a href='/topic/show?id=1085e4227b3' target=_blank style='color:#2F92EE;'>#神经功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74227, encryptionId=1085e4227b3, topicName=神经功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02a927064964, createdName=songbq, createdTime=Mon Mar 02 02:56:00 CST 2015, time=2015-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15798, encodeId=c4ec15e98a4, content=以阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:06:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264216, encodeId=24ac126421651, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421017, encodeId=3e30142101e0d, content=<a href='/topic/show?id=09d33294eb8' target=_blank style='color:#2F92EE;'>#功能障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32947, encryptionId=09d33294eb8, topicName=功能障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3493649807, createdName=naiwu78, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422045, encodeId=1382142204586, content=<a href='/topic/show?id=e5f0e42224f' target=_blank style='color:#2F92EE;'>#神经功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74222, encryptionId=e5f0e42224f, topicName=神经功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85503680375, createdName=lhlxtx, createdTime=Thu Feb 12 01:56:00 CST 2015, time=2015-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15320, encodeId=5936153204c, content=样本太少, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=14.29.111.**, createdTime=Tue Feb 10 14:34:00 CST 2015, time=2015-02-10, status=1, ipAttribution=)]
    2015-02-10 14.29.111.**

    样本太少

    0

相关资讯

Lancet Neurol.:脑出血研究进展面面观

 高血压是脑出血诊治的核心,其不仅是脑出血最主要的危险因素,也是对患者预后进行判断的重要指标。但血压变异性在脑出血诊治及患者预后评估中的作用尚不明确。几年前,研究者更多关注缺血性卒中复发与血压变异性的关系。在本次大会上,澳大利亚安德森(Craig Anderson)教授报告了INTERACT2研究事后分析的结果。研究者发现,以血压标准差作为血压变异指标,在脑出血的超急期

JAMA:急救车溶栓治疗的评估

卒中是致死致残的主要疾病之一。在急性缺血性卒中时,一旦经脑成像排除脑出血后,使用组织性纤溶酶原激活剂(tPA)进行溶栓是主要的治疗选择。溶栓时间对急性缺血性卒中的预后至关重要。 在脑卒中时,神经元快速死亡,并且随机安慰剂对照试验显示tPA有时间依赖性效果:越早用于治疗(90min以内),预后越好。然而,只有少数卒中患者接受tPA溶栓治疗,并且根据欧洲卒中登记情况显示,这少数人中只有11%的患

Neurology:维生素K拮抗剂增加脑出血复发风险

脑出血后,如何进行抗凝治疗,是临床上亟待解决的问题。来自意大利佛罗伦萨大学careggi医院的Daniela Poli博士及其合作者,对有脑出血病史的患者使用vk拮抗剂(VKAs)抗凝治疗后复发脑出血的风险进行了评估,结果在线发表在2月21日的Neurology杂志上。这是一项脑出血患者重启口服抗凝剂治疗研究(CHIRONE Study),收集了隶属于意大利抗凝门诊联盟(FCSA)的27个数据库中

JNS特刊:抗凝药物相关性脑出血的处理

《神经外科学杂志(Journal of Neurosurgery)》8月1日发表特刊“争分夺秒:克服抗凝药物相关性脑出血治疗难题”,这20页的内容包括了目前对于抗凝药物相关性脑出血(AAICH)的已有认识以及现阶段所使用的该情况的处理方法。该增刊可在以下地址免费查阅:http://thejns.org/toc/sup/121/Suppl。 脑出血(ICH)是一种可能致

AANS 2014:基因与脑出血导致的水肿相关联

来自美国旧金山的新闻——一项最新研究显示,一个基因可能强烈影响脑出血所致的血肿周围水肿的量,该研究作为一篇摘要,于2014 年 4 月 8 日发表在美国神经外科医师协会(AANS)第 82 届年度会议上。该基因发生突变的患者的水肿量更大,是没有发生突变的患者的3.39倍。"甚至当你控制了这些患者的临床结果的主要预测因素,该基因对血肿和水肿体积的明显影响仍旧如此大,足以确认该基因是一个独立的关联因素

Lancet Neurol:急性脑出血后血压波动或影响预后

脑血管意外的血压控制,在第6版的内科学教材中明确指出,脑出血时,降血压的指征是血压高于200/130mmHg,一般降至不低于160/100mmHg,原因是其过快降低血压可加重脑出血的情况,而缺血性脑卒中一般不行降血压治疗。因为短期内血压可恢复正常。同时提到降血压治疗时间是24小时降低25%左右,48小时不低于160/100mmHg,1~2星期降至正常水平。高血压是主要影响脑出血预后的因素之一,而且